In addition, the combination of MIF and the EBV viral capsid antigen antibody (VCA-IgA) has been shown to enhance the specificity and predictive value of detecting NPC and to improve the diagnostic accuracy of NPC in high-risk individuals (134). Here, CD79A is linked to nasopharyngeal carcinoma.